Evidence map›Paper›PMID 35406282›Full record

ReviewPolymers2022

Recent Strategies for the Immobilization of Therapeutic Enzymes.

Chen-Yuan Zhu, Fei-Long Li, Ye-Wang Zhang, Rahul K Gupta, Sanjay K S Patel, Jung-Kul Lee

Abstract readReview
In one paragraph

Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Materials (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Emerging Field of Nanotechnology in Environment.Indian journal of microbiology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The structures and applications of microbial chondroitin AC lyase.World journal of microbiology & biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen-Yuan ZhuSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Fei-Long LiSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Ye-Wang ZhangSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China.ORCID 0000-0003-0873-0721
Rahul K GuptaDepartment of Chemical Engineering, Konkuk University, Seoul 05029, Korea.
Sanjay K S PatelDepartment of Chemical Engineering, Konkuk University, Seoul 05029, Korea.ORCID 0000-0003-1658-0911
Jung-Kul LeeDepartment of Chemical Engineering, Konkuk University, Seoul 05029, Korea.

Funding

National Research Foundation of Korea 2019R1C1C11009766National Research Foundation of Korea 2020R1A4A2002854National Research Foundation of Korea 2021M3A9I5023254
6 · The paper itself

Abstract

Therapeutic enzymes play important roles in modern medicine due to their high affinity and specificity. However, it is very expensive to use them in clinical medicine because of their low stability and bioavailability. To improve the stability and effectiveness of therapeutic enzymes, immobilization techniques have been employed to enhance the applications of therapeutic enzymes in the past few years. Reported immobilization techniques include entrapment, adsorption, and covalent attachment. In addition, protein engineering is often used to improve enzyme properties; however, all methods present certain advantages and limitations. For carrier-bound immobilization, the delivery and release of the immobilized enzyme depend on the properties of the carrier and enzyme. In this review, we summarize the advantages and challenges of the current strategies developed to deliver therapeutic enzymes and provide a future perspective on the immobilization technologies used for therapeutic enzyme delivery.

Indexed as

adsorptioncarriercovalent attachmententrapmentimmobilizationprotein engineeringtherapeutic enzyme

Identifiers

PMID35406282
PMCPMC9003532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.